Insider Transactions in Q4 2024 at Ligand Pharmaceuticals Inc (LGND)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,104
-9.25%
|
$244,064
$116.37 P/Share
|
|
Dec 05
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,859
-7.55%
|
$228,657
$123.51 P/Share
|
|
Nov 27
2024
|
John L Lamattina Director |
SELL
Open market or private sale
|
Direct |
2,406
-7.54%
|
$295,938
$123.65 P/Share
|
|
Nov 27
2024
|
John L Lamattina Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,406
+7.01%
|
$125,112
$52.3 P/Share
|